Pharmaceuticals for the prophylaxis of metastasis, containing a sulphoximine of the general formula <IMAGE> in which A, B, R1 and R2 are defined as in Claim 1, have valuable pharmacological properties, in particular effects inhibiting tumour metastasis.
